Login / Signup
Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
Daniel J Lewis
Y H Kim
Madeleine Duvic
Published in:
The British journal of dermatology (2018)
Keyphrases
</>
hodgkin lymphoma
nk cells